Breast MRI for High-risk Screening (eBook)
XXIII, 376 Seiten
Springer International Publishing (Verlag)
978-3-030-41207-4 (ISBN)
Francesco Sardanelli graduated in Medicine with honors at the University of Genoa in 1982 and post-graduated in Radiodiagnostics with honors at the same University in 1986. He served as a staff radiologist at the San Martino Hospital, Genoa (1987-1999) and as adjunct professor at the University of Genoa (1993-2000). Since 2001, he is director of the department of radiology at the Research Hospital Policlinico San Donato, Milan. Adjunct professor at the University of Milan (2002-2006), he was later appointed as associate professor (2006) and full professor (2015) of radiology. From 2008 to 2010 he was director of the post-graduate school in Nuclear Medicine and since 2015 is Director of the post-graduate school in Radiodiagnostics at the University of Milan. He has been consultant for the Istituto Superiore di Sanità, Rome, Italy, for the national radiological coordination of multicenter studies on breast MRI screening of high-risk women (1998-2009), member of the Research Committee of the European Society of Radiology (2006-2010; 2012-2015), president of the European Society of Breast Imaging (2012-2015) and president of the Italian College of Breast Radiologists by the Italian Society of Medical Radiology (2014-2015). Since 2009, he is Director of the European Network for Assessment of Imaging in Medicine in the context of the European Institute for Biomedical Imaging Research. In 2010 he was co-founder of Breast Centres Certification. Since 2015, he is vice president of the Quality Assurance Scheme Development Group of the European Commission Initiative on Breast Cancer. He was or currently is member of the Editorial Board for several medical journals, including the American Journal of Roentgenology, European Radiology, The Breast, and La Radiologia Medica; since 2017, he is Editor-in-Chief of European Radiology Experimental. He is an honorary member of the British Society of Breast Radiology and of the Iranian Society of Radiology. He has published 7 books, 46 book chapters and over 350 articles.
Franca Podo graduated in physics with honors at the University of Rome 'La Sapienza' in 1967. She has been research associate at the Rockefeller University in the Laboratory directed by Prof. George Némethy (New York, NY, USA, 1971) and visiting associate at the University of Pennsylvania Medical School, Johnson Research Foundation directed by Prof. Britton Chance (Philadelphia, PA, USA, 1972). Affiliated to the Istituto Superiore di Sanità, Rome, she was research investigator at the Physics Laboratory (1969-1976), senior investigator at the Laboratory of Cell Biology and Immunology (1976-1980), and research director at the Laboratory of Cell Biology (1981-2004) and at the Cell Biology and Neurosciences Department (2004-2009). She acted as head of the Physical Biochemistry unit (1982-2004) and head of the Molecular and Cellular Imaging unit (2004-09) at the same institution. She was project leader of three Concerted Actions of the European Community on performance assessment and biomedical applications of magnetic resonance (MR) imaging and spectroscopy equipment (1984-1996) and was the scientific coordinator at the Istituto Superiore di Sanità of the Breast Cancer Risk Italian Projects HIBCRIT-1 (1998-2007) and HIBCRIT2 (2008-09) for a nation-wide evaluation of MRI-including screening of women at high genetic-familial risk, within an Italian Ministry of Health programme. In 2002 she was awarded the Gold Metal of the Italian Discussion Group on Magnetic Resonance and since 2008 she is an honorary member of the Italian Society of Radiology (SIRM). She co-edited five books, an international Newsletter (Eurospin Quarterly,1984-92) and five dedicated issues in international journals; she published 30 book chapters and over 180 peer-reviewed papers (over 130 cited in PubMed), mostly devoted to evaluate the significance of MR spectroscopy signals as non-invasive biomarkers of pathology and response to therapy.
Erscheint lt. Verlag | 13.10.2020 |
---|---|
Zusatzinfo | XXIII, 376 p. 84 illus., 32 illus. in color. |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Chirurgie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
Schlagworte | BRCA1, BRCA 2 • Breast Cancer • High-risk • Hodgking lymphoma survivorship • Magnetic Resonance Imaging • Personalised Medicine • prophylactic mastectomy • Radioprotection • Screening |
ISBN-10 | 3-030-41207-5 / 3030412075 |
ISBN-13 | 978-3-030-41207-4 / 9783030412074 |
Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
Haben Sie eine Frage zum Produkt? |
Größe: 13,3 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich